Description
Uses of Medicine:
Abiraterone 250 mg/500 mg is a CYP17 inhibitor. This medicine is used in combination with prednisone. Patients, Healthcare Professionals (HCPs), or Hospitals can buy Abiraterone 2250 mg/500 mg or 500 mg online from India through THE INDIAN PHARMA (a trusted Abiraterone Supplier, Exporter, and Contract Manufacturer in India) for the management and treatment of prostate cancer. This oral medicine is used for the treatment of metastatic castration-resistant prostate cancer (CRPC) and metastatic high-risk castration-sensitive prostate cancer (CSPC).Abiraterone 250 mg/500 mg is prescribed for adult males and is usually accompanied by steroid medication to alleviate the adverse effects. During early-stage prostate cancer, it is used in combination with testosterone suppression therapy. The medicine is not recommended for women or children. Patients undergoing treatment must use effective contraceptives. The medicine does contain lactose and sodium, thus patients with lactose allergies or who are on a sodium-restricted diet need to speak with their physician.
Before commencing Abiraterone 250 mg/500 mg, patients must notify their doctor of any liver complications, history of hypertension, ischemic heart disease, hyponatremia, diabetes, and any known allergies. It is also crucial to review any other pharmaceutical agents, nutraceuticals, or plant-based medicines that are currently being used to prevent any negative reactions. This medication should not be taken in conjunction with Ra-223, another medication prescribed for prostate cancer. Following the treating physician’s directions as written is very important in avoiding problems and receiving the most benefit from the treatment.
Abiraterone 250 mg/500 mg has some common side effects including swelling of feet or legs, hypertension, and diarrhea. Some patients may also have experienced a reduction of red blood cells which can lead to weakness and fatigue. Reduced libido is another possible side effect. If any side effects become intolerable, patients are advised to consult their doctor without delay.
For safety and added effectiveness, medical attention is necessary during treatment. Checkup appointments for blood tests to check liver function and potassium levels may be necessary. Patients using this drug should stick to a healthy diet, exercise, and drink plenty of water. For best treatment results it is important to follow the recommended guidelines precisely. Never self-prescribe changes from this treatment plan without consulting a medical professional first.
Dosage & Side Effects:
Metastatic CRPC: The recommended dose of Abiraterone is 1,000 mg (two 500 mg tablets or four 2250 mg/500 mg tablets) orally once daily in combination with prednisone 5 mg twice daily.
Recommended Dose for Metastatic High-risk CSPC: The recommended dose of Abiraterone is 1,000 mg (two 500 mg tablets or four 2250 mg/500 mg tablets) orally once daily with prednisone 5 mg administered orally once daily.
In patients started on Abiraterone therapy, a GnRH analog must be given simultaneously or the patient must have had a bilateral orchiectomy. Take Abiraterone tablets once daily on an empty stomach. Do not eat 2 hours prior and 1 hour after taking ZYTIGA. Swallow the tablets whole with water. The tablets should not be crushed or chewed.
The most common side effects of Abiraterone 250 mg/500 mg oral tablets are fatigue, hypokalemia, arthralgia, hypertension, vomiting, diarrhea, nausea, edema, hot flush, upper respiratory infection, cough, and headache.
